These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 5520152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J, Mykała-Cieśla J, Machalski M, Drózdz M, Najda J.
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [Abstract] [Full Text] [Related]

  • 3. [Immuno-oncologic monitoring of patients with bronchial carcinoma. IV. Aspects of the immunocompetence system].
    Mancuso M, Leonardo E, Sanfilippo B, Dogliotti C, De Simone M, De Bernochi P, Maggi G.
    Minerva Med; 1985 Mar 31; 76(13):619-26. PubMed ID: 3873024
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The diagnostic significance of the determination of SIgA in the sputum and saliva in lung cancer].
    Chen TJ.
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec 31; 8(6):325-7, 372. PubMed ID: 3836836
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
    Zółtowska A, Skokowski J, Mlekodaj S, Boj E.
    Arch Immunol Ther Exp (Warsz); 1980 Dec 31; 28(4):649-53. PubMed ID: 6970027
    [Abstract] [Full Text] [Related]

  • 10. Immunocompetence in lung cancer patients: analysis of serological and cellular parameters.
    Pierri I, Rogna S, Tavano A, Setti M, Scudeletti M, Ratto G, Motta G, Indiveri F.
    Cancer Detect Prev; 1988 Dec 31; 13(2):95-101. PubMed ID: 3242825
    [Abstract] [Full Text] [Related]

  • 11. [Immunologic status in lung cancer].
    Briusov PG, Polovoĭ AM.
    Sov Med; 1983 Dec 31; (3):16-9. PubMed ID: 6857368
    [No Abstract] [Full Text] [Related]

  • 12. [Activated cells in the peripheral blood in lung cancer].
    Qian L.
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb 31; 11(1):18-21, 62. PubMed ID: 2848634
    [No Abstract] [Full Text] [Related]

  • 13. [Serum concentration of C3 in primary lung cancer patients].
    Bariffi F, Marsico SA, Vigorito C, Alfani G, Donato Di Paola RM.
    Arch Monaldi; 1980 Feb 31; 35(4):169-74. PubMed ID: 6282231
    [No Abstract] [Full Text] [Related]

  • 14. Loss of isoantigens A, B, and H in carcinoma of the lung.
    Davidsohn I, Ni LY.
    Am J Pathol; 1969 Nov 31; 57(2):307-34. PubMed ID: 4902573
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Statistical evaluation of globulin fractions in the course of malignant neoplasia].
    Abeatici S, Lamarca S, Sassi I.
    Arch Sci Med (Torino); 1971 Nov 31; 128(4):231-5. PubMed ID: 5154435
    [No Abstract] [Full Text] [Related]

  • 19. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G, Ferrari S, Megale C, Ippoliti F.
    Boll Ist Sieroter Milan; 1973 Nov 31; 52(3):230-6. PubMed ID: 4762779
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.